Shantha Kumara H M C, Sutton Elli, Bellini Geoffrey A, Yan Xiaohong, Cekic Vesna, Gandhi Nipa Dilip, Whelan Richard L
Division of Colon and Rectal Surgery, Department of Surgery, Mount Sinai West Hospital, New York, NY 10019, USA.
Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Mol Clin Oncol. 2018 Mar;8(3):471-476. doi: 10.3892/mco.2017.1538. Epub 2017 Dec 18.
Minimally invasive colorectal resection (MICR) for colorectal cancer (CRC) is associated with elevated levels of seven proangiogenic proteins that persist for 2-4 weeks after surgery. The proangiogenic plasma may promote tumor growth postoperatively in patients with residual cancer. To the best of our knowledge, the impact of surgery on interleukin 8 (IL-8) levels is unknown. The aim of the present study was to evaluate plasma IL-8 levels after MICR for CRC. Patients with CRC enrolled in an institutional review board-approved plasma/data bank who underwent MICR were eligible. Blood samples were taken preoperatively (preop) and at multiple postoperative (postop) time points, and were stored at -80°C. Only patients for whom preop, postop day (POD) 1, POD 3 and at least 1 late postop plasma samples (POD7-34) available were enrolled. Clinical, demographical and pathological data were collected. IL-8 levels were determined via ELISA and results were reported as the mean and ± standard deviation. The Wilcoxon signed rank test was used for analysis with P<0.05 used as the significance threshold. A total of 73 CRC patients (colon, 62%; rectal, 38%) who underwent MICR (laparoscopic-assisted, 60%; hand-assisted, 40%) were studied. The mean preop IL-8 level was 20.4±10.6 pg/ml. Significant elevations in plasma IL-8 levels were noted compared with preop levels on POD1 (43.1±38.6; n=72; P<0.0001), POD 3 (33.0±30.1; n=71; P<0.0001), POD7-13 (29.9±21.9; n=50; P<0.0001), POD14-20 (33.1±18.3; n=24; P=0.002), and for the POD21-27 time point (24.0±9.2; n=16; P=0.002). In conclusion, plasma IL-8 levels were significantly elevated from baseline for 4 weeks after MICR for CRC. In conjunction with the other proangiogenic MICR-associated blood compositional changes, increased IL-8 levels may promote tumor angiogenesis and growth postop.
结直肠癌的微创结直肠切除术(MICR)与七种促血管生成蛋白水平升高有关,这些蛋白在术后2 - 4周持续存在。促血管生成血浆可能会促进残留癌患者术后的肿瘤生长。据我们所知,手术对白细胞介素8(IL - 8)水平的影响尚不清楚。本研究的目的是评估结直肠癌患者接受MICR术后的血浆IL - 8水平。符合条件的患者为参加了机构审查委员会批准的血浆/数据库且接受了MICR的结直肠癌患者。术前(手术前)和术后多个时间点采集血样,并储存在-80°C。仅纳入术前、术后第1天(POD1)、术后第3天以及至少1份术后晚期血浆样本(POD7 - 34)可用的患者。收集临床、人口统计学和病理数据通过酶联免疫吸附测定(ELISA)测定IL - 8水平,结果以平均值±标准差报告。采用Wilcoxon符号秩检验进行分析,以P < 0.05作为显著性阈值。共研究了73例接受MICR的结直肠癌患者(结肠癌,62%;直肠癌,38%)(腹腔镜辅助,60%;手辅助,40%)。术前IL - 8平均水平为20.4±10.6 pg/ml。与术前水平相比,术后第1天(43.1±38.6;n = 72;P < 0.0001)、术后第3天(33.0±30.1;n = 71;P < 0.0001)、术后第7 - 13天(29.9±21.9;n = 50;P < 0.0001)、术后第14 - 20天(33.1±18.3;n = 24;P = 0.002)以及术后第21 - 27天时间点(24.0±9.2;n = 16;P = 0.002)血浆IL - 8水平显著升高。总之,结直肠癌患者接受MICR术后4周内,血浆IL - 8水平较基线显著升高。与其他与MICR相关的促血管生成血液成分变化一起,IL - 8水平升高可能会促进术后肿瘤血管生成和生长。